Implications of High Tumor Burden on Chimeric Antigen Receptor T Cell Immunotherapy

Investigators focus on linking the efficacy and safety of CAR T cell therapy with tumor burden. Emerging clinical approaches to overcome these obstacles and more effectively incorporate this therapeutic strategy into the treatment paradigm of patients with solid malignant tumors are also described.